ESPR

Esperion Therapeutics, Inc. - Common Stock

$56.97 +$2.30 +4.04%


Own 1 of ESPR at $53.70 which is 0.10% of the portfolio.

+$3.27 (+6.09%)

Shares Bought9
Shares Sold8
Total17
Shares Owned1
Last Price$56.97
Total Return$3.48
Range Today$54.05 - $57.39
52 Week Range$10.71 - $65.20
Open$55.18
Market Cap$1.49B
Volume/Average252.50K/974.73K
P/E Ratio-
Dividend/Yield-




Esperion Therapeutics, Inc. is a clinical stage biopharmaceutical company. The company focuses on developing and commercializing first-in-class, oral, low-density lipoprotein cholesterol lowering therapies for the treatment of patients with hypercholesterolemia and other cardiometabolic risk markers. It is in business of researching, developing and commercializing therapies for the treatment of patients with elevated LDL-C. Esperion Therapeutics was founded by Roger S. Newton and Charles L. Bisgaier on January 22, 2008 and is headquartered in Ann Arbor, MI.


Open Positions

Buy Date Buy Price Quote Return $ Return % Owners
12-06-17 15:05 $53.70 $56.97 +$3.27 +6.09% funkmasterflexion

Closed Positions

Buy Date Sell Date Buy Price Sell Price Return $ Return % Owners
08-22-17 17:14 08-23-17 15:14 $44.68 $43.91 -$0.77 -1.72% oriondeimos manthello
11-02-17 19:57 11-09-17 18:23 $46.01 $47.77 +$1.76 +3.83% funkmasterflexion
10-19-17 15:53 10-23-17 17:35 $47.03 $46.04 -$0.99 -2.10% funkmasterflexion michrob genovahero
10-19-17 15:54 10-24-17 15:51 $47.03 $45.34 -$1.69 -3.59% funkmasterflexion michrob genovahero
08-22-17 18:32 08-23-17 18:16 $44.83 $43.86 -$0.97 -2.16% funkmasterflexion manthello
11-02-17 19:43 11-09-17 18:21 $45.47 $47.67 +$2.20 +4.84% funkmasterflexion
10-30-17 14:44 11-06-17 19:03 $46.62 $48.73 +$2.11 +4.53% funkmasterflexion
08-17-17 18:28 08-17-17 21:41 $45.97 $44.53 -$1.44 -3.13% funkmasterflexion